Annual Prostate Cancer Screening Test Appears to Save Lives

	Tweet

Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from Prostate cancer than those who don’t have annual screenings, according to a study presented October 19, 2005, at the American Society for Therapeutic Radiology and Oncology’s 47th Annual Meeting in Denver.

The study shows that over an estimated 10-year period, men who have an annual prostate specific antigen (PSA) test will have a 3.6 percent chance of dying from the disease, compared to 11.3 percent in the general population. Patients who have the test are more likely to be diagnosed with Prostate cancer that is curable in the vast majority of cases, as opposed to aggressive cancers that are less likely to be curable.

“The PSA blood test is the best simple screening test available for Prostate cancer that picks up Prostate cancer earlier, while it’s still curable,” said Jason Efstathiou, M.D., lead author of the study and a resident at the Harvard Radiation Oncology Program in Boston.

A PSA test is a blood test that measures the level of prostate specific antigen, a protein produced by the prostate. Increased levels of PSA may be a sign of Prostate cancer.

The study took place between 1988 and 2002 and involved 1,492 men who were treated for Prostate cancer by the surgical removal of their prostate and whose cancer came back. Among this group, 841 men had yearly PSA tests before their cancer diagnosis, while 611 men were diagnosed by other methods. There are large, randomized trials currently going in both the U.S. and Europe that will further confirm the impact of PSA screening tests among Prostate cancer patients by 2008.

For more information on radiation therapy for Prostate cancer, please visit http://www.rtanswers.org.

Dr. Efstathiou will be presenting the study at 10:15 a.m. on October 19 in Room 304 of the Colorado Convention Center. 

RELATED STORIES:
Prostate cancer screen test flawed   Link Uncovered Between Benign Prostatic Hyperplasia, NSAIDs   Soya products, beans and sunflower seeds reduce risk of contracting prostate cancer   Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues   Low-grade prostate cancer may not require aggressive treatment   Guide aims to help men understand prostate cancer   Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death   Common Genetic Risk Factor for Colorectal and Prostate Cancer Identified   New Study Strengthens Association of Prostate Cancer with Exposure to Agent Orange in Vietnam Vetera   New Web site Helps Doctors and Prostate Cancer Patients Make Better Treatment Choices   Patients who refuse prostate cancer surgery have worse long-term survival   Prostate cancer surgery more costly for obese men   Should older men be screened for prostate cancer?   Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer   PSA levels accurately predict prostate cancer risk in African-American men   Daily drinking may raise risk of several cancers   Profiling prostate cancer   Fatherhood linked to prostate cancer risk   Scientists discover way to block growth of prostate cancer cells   Carcinoma of the Prostate (CAP)   Strict diet program may help prostate cancer   Being active may ward off prostate cancer death

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]